Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrodin Injection in Healthy Chinese Subjects
NCT07422142Phase 1Not yet recruiting
- Start
- Mar 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of gastrodin in delirium. Primary endpoint: Adverse Events. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
gastrodin
03
Conditions
delirium
Beyond the preview
Go deeper on NCT07422142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07422142.